Henrike Potthast

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Ibuprofen**This paper reflects the scientific opinion of the authors and not the policies of regulating agencies.

Henrike Potthast, Jennifer Dressman, Hans E. Junginger et al. · Journal of Pharmaceutical Sciences · 2005 · 233 citations

Drug Safety, Pharmaceutical Science, Bioequivalence +9

Investigation on the Possibility of Biowaivers for Ibuprofen

Covadonga Álvarez, Ignacio Núñez, Juan J. Torrado et al. · Journal of Pharmaceutical Sciences · 2011 · 70 citations

Pharmacology, Pharmacotherapy, Medicine +1

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Niels Eckstein, Lea Röper, Bodo Haas et al. · Journal of Experimental & Clinical Cancer Research · 2014 · 40 citations · Full text

Biopharmaceutical characterization of sotalol-containing oral immediate release drug products

Axel Alt, Henrike Potthast, Juergen Moessinger et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2004 · 29 citations

Pharmaceutical Science, Medicine, Biopharmaceutical Characterization +4

Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO

Luther Gwaza, John Gordon, Jan Welink et al. · European Journal of Clinical Pharmacology · 2012 · 20 citations

Mg Tablets, Statistical Approaches, Bioequivalence +7